Matthew Harrison
Stock Analyst at Morgan Stanley
(3.51)
# 764
Out of 5,178 analysts
712
Total ratings
49.19%
Success rate
3.78%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LEGN Legend Biotech | Maintains: Overweight | $50 → $49 | $17.50 | +180.00% | 15 | Mar 11, 2026 | |
| R Ryder System | Maintains: Positive | $235 → $250 | $199.61 | +25.24% | 2 | Feb 13, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintains: Equal-Weight | $768 → $769 | $760.65 | +1.10% | 59 | Feb 2, 2026 | |
| INSM Insmed | Maintains: Equal-Weight | $157 → $162 | $149.62 | +8.27% | 20 | Jan 30, 2026 | |
| GILD Gilead Sciences | Maintains: Overweight | $151 → $150 | $137.56 | +9.04% | 44 | Jan 13, 2026 | |
| MRNA Moderna | Maintains: Equal-Weight | $30 → $28 | $53.42 | -47.59% | 27 | Dec 12, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $149 → $156 | $190.99 | -18.32% | 56 | Dec 12, 2025 | |
| ARGX argenx SE | Maintains: Overweight | $1,070 → $1,110 | $696.53 | +59.36% | 27 | Dec 4, 2025 | |
| PHVS Pharvaris | Maintains: Overweight | $37 → $41 | $27.73 | +47.85% | 16 | Dec 4, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Maintains: Equal-Weight | $8 → $4 | $2.63 | +52.09% | 5 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $98 | $55.85 | +75.47% | 23 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $33 → $30 | $20.17 | +48.74% | 13 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $4 | $0.20 | +1,881.17% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $460 → $439 | $455.28 | -3.58% | 41 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $20 | $21.60 | -7.41% | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6.2 → $6 | $5.47 | +9.69% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $5 | $0.70 | +618.60% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $36.21 | +54.65% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $28.67 | +91.84% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $2.12 | +41.84% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $29.15 | -62.26% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $2.31 | +203.03% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $26.25 | +21.90% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $3.70 | +413.51% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $1.55 | -35.48% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $22.74 | -56.02% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $6.97 | +14.78% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $30.36 | +44.93% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $3.08 | +322.76% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $20.20 | +296.04% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $4.52 | +1,227.43% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $88.09 | +145.20% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $3.99 | +25.47% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $4.10 | +21.95% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $210.76 | -13.65% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $40.30 | -77.67% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $352.89 | -20.09% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $331.56 | -36.66% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $27.66 | +88.03% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $241.04 | -28.23% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $20.13 | +496.13% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $8.95 | +1,553.63% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $119.45 | -31.35% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $59.26 | +11.37% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $4.42 | +783.35% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $47.30 | -2.75% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $6.07 | +477.08% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $903.81 | -69.57% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.93 | +549.57% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $8.41 | +637.22% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $15.40 | +12.01% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $93.57 | -11.30% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $63.81 | -84.33% | 4 | Sep 10, 2018 |
Legend Biotech
Mar 11, 2026
Maintains: Overweight
Price Target: $50 → $49
Current: $17.50
Upside: +180.00%
Ryder System
Feb 13, 2026
Maintains: Positive
Price Target: $235 → $250
Current: $199.61
Upside: +25.24%
Regeneron Pharmaceuticals
Feb 2, 2026
Maintains: Equal-Weight
Price Target: $768 → $769
Current: $760.65
Upside: +1.10%
Insmed
Jan 30, 2026
Maintains: Equal-Weight
Price Target: $157 → $162
Current: $149.62
Upside: +8.27%
Gilead Sciences
Jan 13, 2026
Maintains: Overweight
Price Target: $151 → $150
Current: $137.56
Upside: +9.04%
Moderna
Dec 12, 2025
Maintains: Equal-Weight
Price Target: $30 → $28
Current: $53.42
Upside: -47.59%
Biogen
Dec 12, 2025
Maintains: Equal-Weight
Price Target: $149 → $156
Current: $190.99
Upside: -18.32%
argenx SE
Dec 4, 2025
Maintains: Overweight
Price Target: $1,070 → $1,110
Current: $696.53
Upside: +59.36%
Pharvaris
Dec 4, 2025
Maintains: Overweight
Price Target: $37 → $41
Current: $27.73
Upside: +47.85%
Zentalis Pharmaceuticals
Nov 12, 2025
Maintains: Equal-Weight
Price Target: $8 → $4
Current: $2.63
Upside: +52.09%
Oct 28, 2025
Maintains: Overweight
Price Target: $104 → $98
Current: $55.85
Upside: +75.47%
Aug 18, 2025
Maintains: Overweight
Price Target: $33 → $30
Current: $20.17
Upside: +48.74%
Aug 12, 2025
Maintains: Overweight
Price Target: $6 → $4
Current: $0.20
Upside: +1,881.17%
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $460 → $439
Current: $455.28
Upside: -3.58%
Jul 29, 2025
Maintains: Equal-Weight
Price Target: $15 → $20
Current: $21.60
Upside: -7.41%
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $5.47
Upside: +9.69%
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $0.70
Upside: +618.60%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $36.21
Upside: +54.65%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $28.67
Upside: +91.84%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $2.12
Upside: +41.84%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $29.15
Upside: -62.26%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $2.31
Upside: +203.03%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $26.25
Upside: +21.90%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $3.70
Upside: +413.51%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $1.55
Upside: -35.48%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $22.74
Upside: -56.02%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $6.97
Upside: +14.78%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $30.36
Upside: +44.93%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $3.08
Upside: +322.76%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $20.20
Upside: +296.04%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $4.52
Upside: +1,227.43%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $88.09
Upside: +145.20%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.99
Upside: +25.47%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $4.10
Upside: +21.95%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $210.76
Upside: -13.65%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $40.30
Upside: -77.67%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $352.89
Upside: -20.09%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $331.56
Upside: -36.66%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $27.66
Upside: +88.03%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $241.04
Upside: -28.23%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $20.13
Upside: +496.13%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $8.95
Upside: +1,553.63%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $119.45
Upside: -31.35%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $59.26
Upside: +11.37%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $4.42
Upside: +783.35%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $47.30
Upside: -2.75%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $6.07
Upside: +477.08%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $903.81
Upside: -69.57%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.93
Upside: +549.57%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $8.41
Upside: +637.22%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $15.40
Upside: +12.01%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $93.57
Upside: -11.30%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $63.81
Upside: -84.33%